SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-18-002749
Filing Date
2018-09-14
Accepted
2018-09-14 08:07:03
Documents
36
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR JUNE 30, 2018 cannapharmarx_10q-063018.htm 10-Q 188511
2 CERTIFICATION cannapharmarx_10q-ex3101.htm EX-31.1 8444
3 CERTIFICATION cannapharmarx_10q-ex3102.htm EX-31.2 7975
4 CERTIFICATION cannapharmarx_10q-ex32.htm EX-32 4322
  Complete submission text file 0001683168-18-002749.txt   1001195

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cpmd-20180630.xml EX-101.INS 109872
6 XBRL SCHEMA FILE cpmd-20180630.xsd EX-101.SCH 12533
7 XBRL CALCULATION FILE cpmd-20180630_cal.xml EX-101.CAL 23890
8 XBRL DEFINITION FILE cpmd-20180630_def.xml EX-101.DEF 17795
9 XBRL LABEL FILE cpmd-20180630_lab.xml EX-101.LAB 91458
10 XBRL PRESENTATION FILE cpmd-20180630_pre.xml EX-101.PRE 71021
Mailing Address 2 PARK PLAZA, STE. 1200-B IRVINE CA 92614
Business Address 2 PARK PLAZA, STE. 1200-B IRVINE CA 92614 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27055 | Film No.: 181070120
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1